Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 14, 2014 - Issue 9
Submit an article Journal homepage
190
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluations

Clinical experience with ramucirumab: outcomes in breast cancer

Geraldine O’Sullivan CoyneNational Cancer Institute, National Institutes of Health National, Center for Cancer Research, Medical Oncology Service, 12N226, Bethesda, MD 20892, USA+1 301 496 4916; +1 301 402 0172; geraldine.o’[email protected]
, MD PhD MRCPI &
Mauricio BurottoNational Cancer Institute, National Institutes of Health National, Center for Cancer Research, Medical Oncology Service, 12N226, Bethesda, MD 20892, USA+1 301 496 4916; +1 301 402 0172; geraldine.o’[email protected]
, MD
Pages 1351-1360 | Published online: 12 Jul 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Peter Norman. (2015) Orphan drug approvals of 2014: Europe and the United States. Expert Opinion on Orphan Drugs 3:4, pages 445-455.
Read now
Giuseppe Aprile, Erika Rijavec, Caterina Fontanella, Karim Rihawi & Francesco Grossi. (2014) Ramucirumab: preclinical research and clinical development. OncoTargets and Therapy 7, pages 1997-2006.
Read now

Articles from other publishers (2)

Shaker A. Mousa, Thangirala Sudha & Paul J. Davis. 2017. Anti-Angiogenesis Strategies in Cancer Therapeutics. Anti-Angiogenesis Strategies in Cancer Therapeutics 147 163 .
Jiping Liu, Ya-Hui Deng, Ling Yang, Yijuan Chen, Manzo Lawali, Li-Ping Sun & Yu Liu. (2015) CPU-12, a novel synthesized oxazolo[5,4-d]pyrimidine derivative, showed superior anti-angiogenic activity. Journal of Pharmacological Sciences 129:1, pages 9-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.